3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
6
Carcinoma, Basal Cell
4
Uterine Cervical Dysplasia
3
Squamous Intraepithelial Lesions
2
HIV Infections
2
Condylomata Acuminata
2
Precancerous Conditions
1
Patient Satisfaction
1
Papillomavirus Infections
1
Paget Disease, Extramammary
1
Hutchinson's Melanotic Freckle
1
Carcinoma, Squamous Cell
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
22
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
15
Papillomavirus Vaccines
9
Vaccines
6
Blood Specimen Collection
4
Watchful Waiting
2
Vaccines, Synthetic
2
Light Coagulation
2
Hepatitis A Vaccines
2
Engerix-B
2
lime
1
halofantrine
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Pentetic Acid
1
Olive Oil
1
Observation
1
Measles-Mumps-Rubella Vaccine
1
Laser Therapy
1
Injections
1
Imiquimod
1
Human Papillomavirus DNA Tests
1
Fluorouracil
1
Diphtheria-Tetanus-acellular Pertussis Vaccines
1
DTPa-HBV-IPV combined vaccine
1
Colposcopy
1
Clinical Protocols
1
Cisplatin
1
Circumcision, Male
1
Chorionic Villi Sampling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Papillomavirus Infections
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts